Theralink Technologies(THER)
$0.02+0.00 (+100.00%)
THER
Theralink Technologies financials statements
$0.02
At close:+0.00 (+100.00%)
Theralink Technologies (THER) Ratios
39 Followers
Theralink Technologies Ratios
THER's free cash flow for Q4 2023 was $-1.66M. For the 2023 fiscal year, THER's free cash flow was decreased by $-155.40K and operating cash flow was $-1.50M. See a summary of the company’s cash flow.
| Ratios | Sep 23 | Sep 22 | Sep 21 | Sep 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.03 | 0.19 | 0.19 | 1.74 | 0.00 |
| Quick Ratio | 0.03 | 0.19 | 0.17 | 1.68 | 0.00 |
| Cash Ratio | 0.03 | 0.11 | 0.10 | 1.49 | 0.00 |
| Solvency Ratio | -0.75 | -1.96 | -1.51 | -2.06 | -0.70 |
| Operating Cash Flow Ratio | -0.14 | -1.56 | -1.45 | -2.91 | -0.07 |
| Short-Term Operating Cash Flow Coverage | -0.31 | -3.77 | -25.01 | -43.84 | -0.34 |
| Net Current Asset Value | $ -39.70M | $ -5.75M | $ -2.95M | $ 564.23K | $ -15.97M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 6.93 | 1.68 | 0.29 | 0.12 | 36.92 |
| Debt-to-Equity Ratio | -0.52 | -1.15 | -0.25 | 0.23 | -0.22 |
| Debt-to-Capital Ratio | -1.08 | 7.63 | -0.33 | 0.19 | -0.28 |
| Long-Term Debt-to-Capital Ratio | -0.03 | -3.44 | -0.17 | 0.16 | 0.00 |
| Financial Leverage Ratio | -0.07 | -0.68 | -0.84 | 1.89 | -0.01 |
| Debt Service Coverage Ratio | -0.72 | -4.54 | -17.62 | -29.80 | -0.68 |
| Interest Coverage Ratio | -0.53 | -10.63 | -45.96 | -107.53 | -0.99 |
| Debt to Market Cap | 356.94 | 21.25 | 0.18 | 1.47 | 73.21 |
| Interest Debt Per Share | 0.60 | 0.09 | 0.01 | 0.50 | 10.66 |
| Net Debt to EBITDA | -2.15 | -0.35 | -0.03 | 0.43 | -1.96 |
| Profitability Margins | |||||
| Gross Profit Margin | 79.20% | 60.40% | 76.77% | 70.98% | 0.00% |
| EBIT Margin | -1479.80% | -2049.64% | -1100.86% | -1852.24% | 0.00% |
| EBITDA Margin | -1439.10% | -2016.05% | -1064.12% | -1792.78% | 0.00% |
| Operating Profit Margin | -1479.80% | -2049.64% | -1100.86% | -1852.24% | 0.00% |
| Pretax Profit Margin | -5093.56% | -2243.68% | -1082.20% | -1749.32% | 0.00% |
| Net Profit Margin | -5093.56% | -2244.96% | -1106.15% | -1772.06% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | -2244.96% | -1106.15% | -1772.06% | 0.00% |
| Net Income Per EBT | 100.00% | 100.06% | 102.21% | 101.30% | 119.10% |
| EBT Per EBIT | 344.21% | 109.47% | 98.31% | 94.44% | 531.63% |
| Return on Assets (ROA) | -1084.55% | -490.56% | -341.32% | -100.48% | -11886.46% |
| Return on Equity (ROE) | 81.09% | 335.41% | 287.49% | -189.76% | 70.26% |
| Return on Capital Employed (ROCE) | 24.28% | 1358.53% | 335.80% | -167.39% | 11.10% |
| Return on Invested Capital (ROIC) | 48.92% | -2028.81% | 379.57% | -161.03% | 14.19% |
| Return on Tangible Assets | -1084.55% | -490.56% | -341.32% | -100.48% | -11886.46% |
| Earnings Yield | -55826.50% | -6193.70% | -208.31% | -1204.28% | -23571.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 25.38 | 17.68 | 21.94 | 12.08 | 0.00 |
| Payables Turnover | 0.10 | 0.30 | 0.11 | 0.09 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 1.65 | 0.74 | 0.00 |
| Fixed Asset Turnover | 0.39 | 0.30 | 0.52 | 0.16 | 0.00 |
| Asset Turnover | 0.21 | 0.22 | 0.31 | 0.06 | 0.00 |
| Working Capital Turnover Ratio | -0.03 | -0.21 | -0.57 | -0.02 | 0.00 |
| Cash Conversion Cycle | -3539.56 | -1192.00 | -2940.04 | -3758.70 | 0.00 |
| Days of Sales Outstanding | 14.38 | 20.65 | 16.64 | 30.21 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 220.83 | 495.13 | 0.00 |
| Days of Payables Outstanding | 3553.94 | 1212.65 | 3177.50 | 4284.04 | 0.00 |
| Operating Cycle | 14.38 | 20.65 | 237.46 | 525.34 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.09 | -0.09 | -0.09 | -4.10 | -2.37 |
| Free Cash Flow Per Share | -0.10 | -0.09 | -0.09 | -4.73 | -2.37 |
| Dividend Paid and CapEx Coverage Ratio | -30.45 | -16.28 | -0.00 | -0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -35.35 | -40.95 | -35.23 | -6.53 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.29 | -1.23 | -9.98 | -8.85 | -0.34 |
| Operating Cash Flow to Sales Ratio | -9.52 | -9.49 | -9.46 | -19.15 | 0.00 |
| Free Cash Flow Yield | -10725.90% | -2682.30% | -183.13% | -1500.83% | -2465.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.00 | -0.02 | -0.48 | -0.08 | -0.00 |
| Price-to-Sales (P/S) Ratio | 0.09 | 0.36 | 5.31 | 1.47 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.00 | -0.05 | -1.38 | 0.16 | -0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.01 | -0.04 | -0.55 | -0.07 | -0.04 |
| Price-to-Operating Cash Flow Ratio | -0.01 | -0.04 | -0.56 | -0.08 | -0.04 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | -2.16 | -0.37 | -0.53 | 0.34 | -1.98 |
| Enterprise Value | 18.82M | 4.19M | 2.85M | -1.12M | 3.50M |
| EV to EBITDA | -2.16 | -0.37 | -0.53 | 0.34 | -1.98 |
| EV to Sales | 31.01 | 7.37 | 5.64 | -6.18 | 0.00 |
| EV to Free Cash Flow | -3.17 | -0.76 | -0.58 | 0.28 | -2.99 |
| EV to Operating Cash Flow | -3.26 | -0.78 | -0.60 | 0.32 | -2.99 |
| Tangible Book Value Per Share | -0.62 | -0.06 | -0.04 | 2.00 | -32.21 |
| Shareholders’ Equity Per Share | -0.62 | -0.06 | -0.04 | 2.00 | -32.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.54 | -0.00 | -0.02 | -0.01 | -0.19 |
| Revenue Per Share | 0.01 | 0.01 | 0.01 | 0.21 | 0.00 |
| Net Income Per Share | -0.50 | -0.22 | -0.10 | -3.79 | -22.63 |
| Tax Burden | 1.00 | 1.00 | 1.02 | 1.01 | 1.19 |
| Interest Burden | 3.44 | 1.09 | 0.98 | 0.94 | 5.32 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 15.07 | 21.10 | 11.78 | 19.23 | 0.00 |
| Stock-Based Compensation to Revenue | 2.06 | 10.59 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.19 | 0.42 | 0.87 | 1.09 | 0.12 |
Currency in USD
